neratinib
Showing 26 - 50 of 58
Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations Trial in Worldwide (Neratinib, Fulvestrant, Trastuzumab)
Active, not recruiting
- Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
- Neratinib
- +2 more
-
Birmingham, Alabama
- +59 more
Mar 3, 2022
Biliary Tract Tumors Trial in Belgium, France, United Kingdom (Futibatinib, Ivosidenib, Zanidatamab)
Not yet recruiting
- Biliary Tract Neoplasms
- Futibatinib
- +9 more
-
Brussels, Belgium
- +56 more
Nov 7, 2022
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
HER2+ Metastatic Breast Cancer (MBC) Trial in Worldwide (neratinib, capecitabine, lapatinib)
Completed
- HER2+ Metastatic Breast Cancer (MBC)
- neratinib
- +2 more
-
Chandler, Arizona
- +251 more
May 18, 2021
Advanced Malignant Solid Tumors Trial in Shizuoka, Tokyo (Neratinib, Capecitabine)
Completed
- Advanced Malignant Solid Tumors
- Neratinib
- Capecitabine
-
Shizuoka, Japan
- +1 more
Dec 18, 2018
Advanced Malignant Solid Tumors Trial in Shizuoka, Tokyo (Neratinib, Paclitaxel)
Tumors, Malignant Carcinoma Trial in Boston, Villejuif (Neratinib, Temsirolimus)
Completed
- Neoplasms
- Malignant Carcinoma
- Neratinib
- Temsirolimus
-
Boston, Massachusetts
- +4 more
Aug 17, 2018
Advanced Malignant Solid Tumors Trial in Shizuoka, Tokyo (Neratinib, Vinorelbine)
Completed
- Advanced Malignant Solid Tumors
- Neratinib
- Vinorelbine
-
Shizuoka, Japan
- +1 more
Apr 24, 2018
HER2-mutant NSCLC Trial in France, United States (neratinib, temsirolimus)
Completed
- HER2-mutant Non-Small Cell Lung Cancer
- neratinib
- temsirolimus
-
Duarte, California
- +20 more
May 31, 2018
Advanced Breast Cancer Trial in United Kingdom (Fulvestrant, Neratinib, AZD5363)
Recruiting
- Advanced Breast Cancer
- Fulvestrant
- +4 more
-
Sutton, England, United Kingdom
- +18 more
Jan 17, 2019
Solid Tumor Trial in San Francisco (Neratinib, Paclitaxel, Pertuzumab)
Terminated
- Solid Tumor
- Neratinib
- +3 more
-
San Francisco, CaliforniaUCSF Helen Diller Family Comprehensive Cancer Center
Nov 13, 2017
Breast Cancer, Advanced Malignant Solid Tumors Trial in Worldwide (neratinib, vinorelbine)
Completed
- Breast Cancer
- Advanced Malignant Solid Tumors
- neratinib
- vinorelbine
-
Fayetteville, Arkansas
- +34 more
Jul 11, 2018
Healthy Trial in Tacoma (neratinib)
Completed
- Healthy
- neratinib
-
Tacoma, WashingtonNorthwest Kinetics
Sep 6, 2017
Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Neratinib, Lapatinib, Capecitabine)
Completed
- Advanced Breast Cancer
- Breast Cancer
- Neratinib
- +2 more
-
Tucson, Arizona
- +151 more
Jul 11, 2018
Bladder Cancer Trial in Chapel Hill (Neratinib)
No longer available
- Bladder Cancer
- Neratinib
-
Chapel Hill, North CarolinaNorth Carolina Cancer Hospital (UNC)
Mar 10, 2017
Neratinib In Healthy Subjects
Completed
- Healthy
- Neratinib
-
New Haven, ConnecticutInvestigational Site
May 10, 2012
Healthy Subjects Trial in Miami (Neratinib)
Completed
- Healthy Subjects
- Neratinib
-
Miami, Florida(unnamed)
May 10, 2012